Background and Biological Function of CABP2

Calcium-binding protein 2 (CABP2) is a member of the calmodulin superfamily and the CaBP subfamily of EF-hand calcium-binding proteins. CABP2 is predominantly expressed in sensory hair cells of the inner ear, where it plays a critical role in modulating voltage-gated calcium channels (Cav1.3), which are essential for auditory signal transduction. Mutations in the CABP2 gene have been associated with autosomal recessive non-syndromic hearing loss (DFNB93) in humans, underscoring its physiological importance in auditory function.

Beyond auditory biology, CABP2 interacts with multiple intracellular targets in a calcium-dependent manner, influencing neuronal signaling pathways. Recombinant Human CABP2 Protein enables researchers to investigate these molecular interactions under defined, controlled in vitro conditions.

Materials and Reconstitution Procedure

Materials Required:

• Recombinant Human CABP2 Protein (rp372662, Aladdin Scientific)
• Sterile, nuclease-free water or suitable reconstitution buffer (e.g., PBS, pH 7.4, or as specified on the product datasheet)
• Sterile microcentrifuge tubes (low-binding recommended)
• Micropipettes and calibrated tips
• Ice bucket or cooling block
• Microcentrifuge

Reconstitution Steps:

1. Allow the lyophilized protein vial to equilibrate to room temperature (approximately 10–15 minutes) before opening to minimize moisture condensation.
2. Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to ensure the lyophilized material is collected at the bottom.
3. Add the recommended volume of sterile reconstitution buffer dropwise along the inner wall of the vial. Consult the product datasheet for the exact volume to achieve the desired stock concentration.
4. Gently swirl or pipette up and down to dissolve the protein. Do NOT vortex, as mechanical shear can denature the protein.
5. Allow the solution to stand on ice for 5 minutes to ensure complete dissolution, then centrifuge briefly to remove any insoluble material.
6. Visually inspect the solution; it should be clear and colorless to slightly opalescent. Discard if the solution appears turbid or contains visible aggregates.

Note: Always consult the specific product datasheet (absea#PP-6648) for lot-specific reconstitution instructions and concentration recommendations.

Storage, Stability, and Handling Best Practices

Storage Conditions:

• Long-term storage: Store lyophilized and reconstituted protein at -80°C.
• Short-term storage: Reconstituted protein may be stored at 4°C for up to 1 week if use is imminent; confirm stability on the product datasheet.
• Avoid repeated freeze-thaw cycles, as these significantly reduce protein activity. Prepare single-use aliquots after reconstitution.

Handling Best Practices:

• Always work on ice when handling reconstituted protein.
• Use low-binding microcentrifuge tubes and pipette tips to minimize protein loss due to adsorption.
• Do not expose the protein to detergents unless required by the assay, as surfactants can disrupt protein folding.
• Wear appropriate PPE (gloves, lab coat, eye protection) as with all research-grade biological reagents.
• Record the date of reconstitution on the vial and discard aliquots beyond the recommended stability window.

Experimental Applications and Working Concentration Guidelines

Recombinant Human CABP2 Protein is suitable for a range of in vitro applications. The following guidelines are based on general best practices for recombinant EF-hand calcium-binding proteins; researchers should optimize conditions empirically for their specific assay system:

• Binding and interaction studies (e.g., pull-down, co-IP): Typical working concentrations range from 0.1–10 µg per reaction. Titrate to determine optimal conditions.
• Biochemical activity assays (e.g., calcium-dependent channel modulation): Optimize based on the specific assay format and target protein concentration. Include appropriate positive and negative controls.
• Structural studies (e.g., SPR, ITC, NMR): Higher purity and concentration preparations may be required; consult the product datasheet for purity specifications.
• Cell-based studies: If used extracellularly or delivered intracellularly, validate delivery efficiency and confirm cellular uptake or effect by appropriate readout (e.g., Western blot, immunofluorescence).

Always include a no-protein negative control and, where applicable, a denatured-protein control to confirm specificity of observed effects. Specific working concentrations should be validated empirically for each experimental system.

Quality Control and Troubleshooting

Quality Control Checks:

• Verify protein identity and molecular weight by SDS-PAGE and/or Western blot using a validated anti-CABP2 antibody prior to experimental use.
• Assess protein concentration using a standard protein quantification method (e.g., BCA or Bradford assay) compatible with the reconstitution buffer.
• Confirm biological activity where possible using a validated functional assay (e.g., calcium-binding assay or Cav1.3 modulation assay).

Common Issues and Troubleshooting: